CBUS
Price
$1.77
Change
+$0.05 (+2.91%)
Updated
Jul 23, 04:59 PM (EDT)
Capitalization
83.22M
CRBU
Price
$2.48
Change
+$0.10 (+4.22%)
Updated
Jul 23, 04:59 PM (EDT)
Capitalization
220.42M
20 days until earnings call
Interact to see
Advertisement

CBUS vs CRBU

Header iconCBUS vs CRBU Comparison
Open Charts CBUS vs CRBUBanner chart's image
Cibus
Price$1.77
Change+$0.05 (+2.91%)
Volume$2.15K
Capitalization83.22M
Caribou Biosciences
Price$2.48
Change+$0.10 (+4.22%)
Volume$12.44K
Capitalization220.42M
CBUS vs CRBU Comparison Chart in %
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CBUS vs. CRBU commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a Hold and CRBU is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (CBUS: $1.65 vs. CRBU: $2.07)
Brand notoriety: CBUS and CRBU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 41% vs. CRBU: 160%
Market capitalization -- CBUS: $83.22M vs. CRBU: $220.42M
CBUS [@Biotechnology] is valued at $83.22M. CRBU’s [@Biotechnology] market capitalization is $220.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $284.45B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileCRBU’s FA Score has 1 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • CRBU’s FA Score: 1 green, 4 red.
According to our system of comparison, CRBU is a better buy in the long-term than CBUS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 3 TA indicator(s) are bullish while CRBU’s TA Score has 3 bullish TA indicator(s).

  • CBUS’s TA Score: 3 bullish, 5 bearish.
  • CRBU’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than CBUS.

Price Growth

CBUS (@Biotechnology) experienced а +7.14% price change this week, while CRBU (@Biotechnology) price change was +21.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.08%. For the same industry, the average monthly price growth was +21.29%, and the average quarterly price growth was +31.06%.

Reported Earning Dates

CBUS is expected to report earnings on May 08, 2025.

CRBU is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+7.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRBU($220M) has a higher market cap than CBUS($83.2M). CRBU YTD gains are higher at: 30.189 vs. CBUS (-40.647). CRBU has higher annual earnings (EBITDA): -159.14M vs. CBUS (-264.18M). CRBU has more cash in the bank: 208M vs. CBUS (23.6M). CRBU has less debt than CBUS: CRBU (26.2M) vs CBUS (35.6M). CRBU has higher revenues than CBUS: CRBU (9.92M) vs CBUS (4.75M).
CBUSCRBUCBUS / CRBU
Capitalization83.2M220M38%
EBITDA-264.18M-159.14M166%
Gain YTD-40.64730.189-135%
P/E RatioN/AN/A-
Revenue4.75M9.92M48%
Total Cash23.6M208M11%
Total Debt35.6M26.2M136%
FUNDAMENTALS RATINGS
CBUS: Fundamental Ratings
CBUS
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CBUSCRBU
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 2 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
CBUS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AINSF0.620.02
+3.33%
Ainsworth Game Technology Ltd.
HLYK0.03N/A
+0.24%
HealthLynked Corp.
HGKGF6.30N/A
N/A
Power Assets Holdings Ltd.
OSTIY15.59N/A
N/A
Osterreichische Post AG
BKAMF14.33N/A
N/A
BROOKFIELD CORP.

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with ARCT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-1.79%
ARCT - CBUS
42%
Loosely correlated
+2.15%
CRBU - CBUS
38%
Loosely correlated
+0.98%
ABOS - CBUS
36%
Loosely correlated
+3.33%
CGEM - CBUS
36%
Loosely correlated
-0.13%
RXRX - CBUS
35%
Loosely correlated
+9.59%
More

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
+0.98%
CRSP - CRBU
63%
Loosely correlated
+0.31%
BEAM - CRBU
56%
Loosely correlated
+1.35%
RXRX - CRBU
54%
Loosely correlated
+9.59%
CCCC - CRBU
54%
Loosely correlated
-2.37%
NTLA - CRBU
53%
Loosely correlated
+4.73%
More